• European Stocks Close Higher on US Earnings Wednesday, 17 Oct 2007 | 11:33 AM ET

    Europe's major stock indexes closed higher Wednesday, following a mixed morning, as a strong set of earnings from the likes of Coca-Cola and JPMorgan boosted investor confidence.

  • Munich Re to Buy US Insurer Midland for $1.3 Billion Wednesday, 17 Oct 2007 | 3:21 AM ET

    German reinsurance company Munich Re will acquire specialty insurance company Midland for $1.3 billion, or $65 per share in a bid to expand in the US, the companies said on Wednesday.

  • “Power Lunch” is in Seattle to focus on the things that put the Pacific Northwest on the map, including the Internet and socially-conscious energy. Here's what some of the guests on the program are saying.

  • Resolution Rejects Pearl's Bid Thursday, 11 Oct 2007 | 12:25 AM ET

    British life insurer Resolution on Wednesday rejected a takeover approach from rival Pearl that valued it at around 4.5 billion pounds ($9.2 billion).

  • Ambac Issues Third-Quarter Earnings Warning Wednesday, 10 Oct 2007 | 5:39 PM ET

    Ambac Financial Group, one of the world's largest bond insurers, warned on Wednesday that it expects to report a third-quarter net loss after taking a $743 million write-down on its credit derivative portfolio.

  • Allianz Keeps Forecast Despite Credit Problems: Report Wednesday, 10 Oct 2007 | 2:39 AM ET

    German insurer Allianz is sticking to its full-year earnings forecast despite the impact of a credit crisis that will weigh on the trading result at its Dresdner Bank unit in the third qarter, its finance chief told Boerse Online magazine.

  • Jack Welch, Former CEO & Chairman, GE Friday, 5 Oct 2007 | 12:31 PM ET

    Discussing leadership, motivation and career success with Jack Welch, former General Electric chairman & CEO.

  • Pfizer's Got Talent! (Auditions In A City Near You) Wednesday, 3 Oct 2007 | 10:39 AM ET

    Pfizer put out a press release this morning announcing that it has added another office in the C-Suite. The world's biggest drug company has hired a CTO. What's a CTO, you ask?? Well, it doesn't stand for what you might guess--Chief Technology Officer. Nope, Pfizer has created the position of Chief Talent Officer.

  • Cramer's Must-Go CEO Monday, 1 Oct 2007 | 10:55 AM ET

    The head of Marsh & Mclennan either needs to pack up shop or split his company up if he wants out of Cramer's Hall of Shame.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Benfield Shares Jump on Reported Goldman Approach Friday, 28 Sep 2007 | 6:06 AM ET

    Shares in British reinsurance broker Benfield jumped almost 13% on Friday after a report it had received a 700 million pound ($1.4 billion) bid approach from the private equity arm of Goldman Sachs.

  • Pearl Preparing All-Cash Offer for Resolution: FT Thursday, 27 Sep 2007 | 9:11 AM ET

    Insurer Pearl is preparing to make an all-cash offer for rival Resolution as early as next week, the Financial Times reported on Thursday.

  • Lloyd's of London First-Half Profit Leaps Thursday, 27 Sep 2007 | 5:39 AM ET

    The Lloyd's of London insurance market's pretax profit for the first six months of the year jumped 34% thanks to high premiums and low catastrophe claims, it said on Thursday.

  • Standard Life Says Mulling Offer for Resolution Wednesday, 19 Sep 2007 | 11:10 AM ET

    U.K. insurer Standard Life is considering a cash-and-shares bid for Resolution, it said on Wednesday, once again throwing into doubt Resolution's agreed nil-premium merger with rival Friends Provident.

  • Marsh & McLennan said Friday that Brian Storms, CEO of the insurance broker's main operating subsidiary Marsh Inc., had been ousted. His departure, effective immediately, follows a 21 percent decline in Marsh & McLennan's stock price since May because of its financial underperformance.

  • ImClone's New CEO: Already Repeating The Past? Wednesday, 12 Sep 2007 | 2:26 PM ET

    Recently I blogged about the hiring of a new CEO at ImClone Systems and the unique clause in his contract requiring him to buy half-a-million dollars worth of stock in the company. My suspicion was that ImClone Chairman and billionaire shareholder Carl Icahn had a hand in that.

  • FDA Meetings And Latest On Biotech Front Tuesday, 11 Sep 2007 | 10:59 AM ET

    So, I thought I'd be spending today monitoring the webcast of the FDA Advisory Committees that are meeting to decide whether doctors should use less of the anemia drugs from Amgen and Johnson & Johnson to treat kidney dialysis patients.

  • Swiss Re said it estimated claims for the industry from natural catastrophes in 2007 would amount to about $35 billion, well above a benign 2006 with $12 billion in natural catastrophe claims.

  • Munich Re Says Reinsurance Price Pressure Rises Monday, 10 Sep 2007 | 12:37 AM ET

    Reinsurers are under rising pressure from their clients to cut premium prices, but levels are still adequate, Munich Re said on Sunday.

  • Advent to Buy Domestic & General for $1 Billion Friday, 7 Sep 2007 | 3:25 AM ET

    Private equity firm Advent International said it had agreed to buy Britain's Domestic & General in a deal that values the domestic appliances insurer at around 523.9 million pounds ($1.06 billion).

  • Pfizer Comes Out Swinging On Lipitor Wednesday, 5 Sep 2007 | 11:02 AM ET

    The gloves are off. Overnight, Pfizer came out with a new study on the world's top-selling drug, Lipitor, for cholesterol. The company says if you switch from its drug to generic Zocor you've got a 30% greater chance of dying from a heart attack, stroke or some other "major cardiovascular" event.

Contact Insurance


    Get the best of CNBC in your inbox

    › Learn More